nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—choroid plexus—malignant glioma	0.112	0.425	CbGeAlD
Valaciclovir—SLC15A2—choroid plexus—malignant glioma	0.0974	0.369	CbGeAlD
Valaciclovir—Altered state of consciousness—Temozolomide—malignant glioma	0.0199	0.0351	CcSEcCtD
Valaciclovir—Encephalopathy—Carmustine—malignant glioma	0.0148	0.0262	CcSEcCtD
Valaciclovir—Tooth disorder—Temozolomide—malignant glioma	0.0142	0.025	CcSEcCtD
Valaciclovir—Menorrhagia—Temozolomide—malignant glioma	0.0124	0.0219	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.0118	0.0697	CbGpPWpGaD
Valaciclovir—SLC6A14—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.0115	0.0683	CbGpPWpGaD
Valaciclovir—Accidental injury—Carmustine—malignant glioma	0.0108	0.019	CcSEcCtD
Valaciclovir—Herpes simplex—Temozolomide—malignant glioma	0.00999	0.0176	CcSEcCtD
Valaciclovir—SLC10A2—Orphan transporters—COX8A—malignant glioma	0.0093	0.0551	CbGpPWpGaD
Valaciclovir—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00921	0.0162	CcSEcCtD
Valaciclovir—Depressed level of consciousness—Carmustine—malignant glioma	0.0092	0.0162	CcSEcCtD
Valaciclovir—Depressed level of consciousness—Temozolomide—malignant glioma	0.00889	0.0157	CcSEcCtD
Valaciclovir—Coma—Carmustine—malignant glioma	0.00871	0.0153	CcSEcCtD
Valaciclovir—Aplastic anaemia—Temozolomide—malignant glioma	0.00865	0.0152	CcSEcCtD
Valaciclovir—SLC6A14—Amine compound SLC transporters—SLC6A3—malignant glioma	0.008	0.0474	CbGpPWpGaD
Valaciclovir—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00768	0.0135	CcSEcCtD
Valaciclovir—Injury—Carmustine—malignant glioma	0.00752	0.0133	CcSEcCtD
Valaciclovir—SLC15A2—retina—malignant glioma	0.00745	0.0283	CbGeAlD
Valaciclovir—SLC10A2—Orphan transporters—APOD—malignant glioma	0.00723	0.0428	CbGpPWpGaD
Valaciclovir—SLC15A2—telencephalon—malignant glioma	0.00685	0.026	CbGeAlD
Valaciclovir—Face oedema—Carmustine—malignant glioma	0.00668	0.0118	CcSEcCtD
Valaciclovir—Ataxia—Carmustine—malignant glioma	0.0065	0.0115	CcSEcCtD
Valaciclovir—Face oedema—Temozolomide—malignant glioma	0.00645	0.0114	CcSEcCtD
Valaciclovir—Liver function test abnormal—Carmustine—malignant glioma	0.00639	0.0113	CcSEcCtD
Valaciclovir—Ataxia—Temozolomide—malignant glioma	0.00629	0.0111	CcSEcCtD
Valaciclovir—Dehydration—Temozolomide—malignant glioma	0.00622	0.011	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00602	0.0106	CcSEcCtD
Valaciclovir—SLC22A6—brain—malignant glioma	0.00594	0.0225	CbGeAlD
Valaciclovir—SLC6A14—NRF2 pathway—FTH1—malignant glioma	0.00593	0.0351	CbGpPWpGaD
Valaciclovir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.0059	0.0104	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.00587	0.0348	CbGpPWpGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00568	0.0336	CbGpPWpGaD
Valaciclovir—Bronchitis—Temozolomide—malignant glioma	0.00556	0.00979	CcSEcCtD
Valaciclovir—SLC15A2—medulla oblongata—malignant glioma	0.00538	0.0204	CbGeAlD
Valaciclovir—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00537	0.00946	CcSEcCtD
Valaciclovir—Depression—Carmustine—malignant glioma	0.00531	0.00936	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00527	0.00929	CcSEcCtD
Valaciclovir—Renal failure—Carmustine—malignant glioma	0.00524	0.00923	CcSEcCtD
Valaciclovir—Stomatitis—Carmustine—malignant glioma	0.0052	0.00915	CcSEcCtD
Valaciclovir—Urinary tract infection—Carmustine—malignant glioma	0.00518	0.00913	CcSEcCtD
Valaciclovir—Depression—Temozolomide—malignant glioma	0.00514	0.00905	CcSEcCtD
Valaciclovir—Stomatitis—Temozolomide—malignant glioma	0.00502	0.00885	CcSEcCtD
Valaciclovir—Urinary tract infection—Temozolomide—malignant glioma	0.00501	0.00882	CcSEcCtD
Valaciclovir—SLC15A2—midbrain—malignant glioma	0.00492	0.0187	CbGeAlD
Valaciclovir—Hepatobiliary disease—Temozolomide—malignant glioma	0.00487	0.00858	CcSEcCtD
Valaciclovir—Sinusitis—Temozolomide—malignant glioma	0.00483	0.00852	CcSEcCtD
Valaciclovir—SLC15A2—spinal cord—malignant glioma	0.0048	0.0182	CbGeAlD
Valaciclovir—Hallucination—Carmustine—malignant glioma	0.00476	0.00839	CcSEcCtD
Valaciclovir—Oedema peripheral—Carmustine—malignant glioma	0.00471	0.00831	CcSEcCtD
Valaciclovir—Hepatitis—Temozolomide—malignant glioma	0.00462	0.00815	CcSEcCtD
Valaciclovir—Hallucination—Temozolomide—malignant glioma	0.0046	0.00811	CcSEcCtD
Valaciclovir—Pharyngitis—Temozolomide—malignant glioma	0.00459	0.00809	CcSEcCtD
Valaciclovir—Urinary tract disorder—Temozolomide—malignant glioma	0.00457	0.00805	CcSEcCtD
Valaciclovir—Oedema peripheral—Temozolomide—malignant glioma	0.00456	0.00803	CcSEcCtD
Valaciclovir—Urethral disorder—Temozolomide—malignant glioma	0.00453	0.00799	CcSEcCtD
Valaciclovir—SLC22A8—central nervous system—malignant glioma	0.00448	0.017	CbGeAlD
Valaciclovir—Erythema multiforme—Temozolomide—malignant glioma	0.00437	0.0077	CcSEcCtD
Valaciclovir—Alopecia—Carmustine—malignant glioma	0.00423	0.00745	CcSEcCtD
Valaciclovir—Immune system disorder—Temozolomide—malignant glioma	0.00418	0.00736	CcSEcCtD
Valaciclovir—Mediastinal disorder—Temozolomide—malignant glioma	0.00417	0.00734	CcSEcCtD
Valaciclovir—Chills—Temozolomide—malignant glioma	0.00415	0.00731	CcSEcCtD
Valaciclovir—Alopecia—Temozolomide—malignant glioma	0.00409	0.0072	CcSEcCtD
Valaciclovir—Back pain—Carmustine—malignant glioma	0.00403	0.0071	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.00403	0.0238	CbGpPWpGaD
Valaciclovir—Tremor—Carmustine—malignant glioma	0.0039	0.00688	CcSEcCtD
Valaciclovir—Back pain—Temozolomide—malignant glioma	0.00389	0.00686	CcSEcCtD
Valaciclovir—SLC15A2—central nervous system—malignant glioma	0.00389	0.0148	CbGeAlD
Valaciclovir—Anaemia—Carmustine—malignant glioma	0.00385	0.00678	CcSEcCtD
Valaciclovir—Agitation—Carmustine—malignant glioma	0.00383	0.00674	CcSEcCtD
Valaciclovir—SLC15A2—cerebellum—malignant glioma	0.00381	0.0144	CbGeAlD
Valaciclovir—Tremor—Temozolomide—malignant glioma	0.00377	0.00665	CcSEcCtD
Valaciclovir—Leukopenia—Carmustine—malignant glioma	0.00373	0.00657	CcSEcCtD
Valaciclovir—Anaemia—Temozolomide—malignant glioma	0.00372	0.00656	CcSEcCtD
Valaciclovir—Agitation—Temozolomide—malignant glioma	0.0037	0.00652	CcSEcCtD
Valaciclovir—Angioedema—Temozolomide—malignant glioma	0.00368	0.00648	CcSEcCtD
Valaciclovir—Convulsion—Carmustine—malignant glioma	0.00361	0.00636	CcSEcCtD
Valaciclovir—Leukopenia—Temozolomide—malignant glioma	0.0036	0.00635	CcSEcCtD
Valaciclovir—Hypertension—Carmustine—malignant glioma	0.0036	0.00634	CcSEcCtD
Valaciclovir—SLC22A8—brain—malignant glioma	0.00356	0.0135	CbGeAlD
Valaciclovir—Chest pain—Carmustine—malignant glioma	0.00355	0.00625	CcSEcCtD
Valaciclovir—Myalgia—Carmustine—malignant glioma	0.00355	0.00625	CcSEcCtD
Valaciclovir—Cough—Temozolomide—malignant glioma	0.00351	0.00619	CcSEcCtD
Valaciclovir—Convulsion—Temozolomide—malignant glioma	0.00349	0.00615	CcSEcCtD
Valaciclovir—Hypertension—Temozolomide—malignant glioma	0.00348	0.00612	CcSEcCtD
Valaciclovir—Confusional state—Carmustine—malignant glioma	0.00343	0.00604	CcSEcCtD
Valaciclovir—Myalgia—Temozolomide—malignant glioma	0.00343	0.00604	CcSEcCtD
Valaciclovir—Arthralgia—Temozolomide—malignant glioma	0.00343	0.00604	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0034	0.006	CcSEcCtD
Valaciclovir—Oedema—Carmustine—malignant glioma	0.0034	0.00599	CcSEcCtD
Valaciclovir—Infection—Carmustine—malignant glioma	0.00338	0.00595	CcSEcCtD
Valaciclovir—Dry mouth—Temozolomide—malignant glioma	0.00335	0.00591	CcSEcCtD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00334	0.0198	CbGpPWpGaD
Valaciclovir—Thrombocytopenia—Carmustine—malignant glioma	0.00333	0.00586	CcSEcCtD
Valaciclovir—Tachycardia—Carmustine—malignant glioma	0.00332	0.00585	CcSEcCtD
Valaciclovir—Confusional state—Temozolomide—malignant glioma	0.00331	0.00584	CcSEcCtD
Valaciclovir—Anaphylactic shock—Temozolomide—malignant glioma	0.00329	0.00579	CcSEcCtD
Valaciclovir—Oedema—Temozolomide—malignant glioma	0.00329	0.00579	CcSEcCtD
Valaciclovir—Infection—Temozolomide—malignant glioma	0.00326	0.00575	CcSEcCtD
Valaciclovir—Anorexia—Carmustine—malignant glioma	0.00324	0.00571	CcSEcCtD
Valaciclovir—Nervous system disorder—Temozolomide—malignant glioma	0.00322	0.00568	CcSEcCtD
Valaciclovir—Thrombocytopenia—Temozolomide—malignant glioma	0.00322	0.00567	CcSEcCtD
Valaciclovir—Skin disorder—Temozolomide—malignant glioma	0.00319	0.00562	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00318	0.0188	CbGpPWpGaD
Valaciclovir—Anorexia—Temozolomide—malignant glioma	0.00313	0.00552	CcSEcCtD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00313	0.0185	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0031	0.00546	CcSEcCtD
Valaciclovir—SLC15A2—brain—malignant glioma	0.00309	0.0117	CbGeAlD
Valaciclovir—Insomnia—Carmustine—malignant glioma	0.00307	0.00542	CcSEcCtD
Valaciclovir—Paraesthesia—Carmustine—malignant glioma	0.00305	0.00538	CcSEcCtD
Valaciclovir—Dyspnoea—Carmustine—malignant glioma	0.00303	0.00534	CcSEcCtD
Valaciclovir—Somnolence—Carmustine—malignant glioma	0.00302	0.00533	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00299	0.00527	CcSEcCtD
Valaciclovir—Insomnia—Temozolomide—malignant glioma	0.00297	0.00524	CcSEcCtD
Valaciclovir—Decreased appetite—Carmustine—malignant glioma	0.00296	0.00521	CcSEcCtD
Valaciclovir—Paraesthesia—Temozolomide—malignant glioma	0.00295	0.0052	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00293	0.00517	CcSEcCtD
Valaciclovir—Dyspnoea—Temozolomide—malignant glioma	0.00293	0.00516	CcSEcCtD
Valaciclovir—Somnolence—Temozolomide—malignant glioma	0.00292	0.00515	CcSEcCtD
Valaciclovir—Pain—Carmustine—malignant glioma	0.00291	0.00512	CcSEcCtD
Valaciclovir—Constipation—Carmustine—malignant glioma	0.00291	0.00512	CcSEcCtD
Valaciclovir—Dyspepsia—Temozolomide—malignant glioma	0.00289	0.0051	CcSEcCtD
Valaciclovir—Decreased appetite—Temozolomide—malignant glioma	0.00286	0.00503	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00284	0.005	CcSEcCtD
Valaciclovir—Fatigue—Temozolomide—malignant glioma	0.00283	0.00499	CcSEcCtD
Valaciclovir—Constipation—Temozolomide—malignant glioma	0.00281	0.00495	CcSEcCtD
Valaciclovir—Pain—Temozolomide—malignant glioma	0.00281	0.00495	CcSEcCtD
Valaciclovir—Feeling abnormal—Carmustine—malignant glioma	0.0028	0.00494	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Carmustine—malignant glioma	0.00278	0.0049	CcSEcCtD
Valaciclovir—Feeling abnormal—Temozolomide—malignant glioma	0.00271	0.00477	CcSEcCtD
Valaciclovir—Body temperature increased—Carmustine—malignant glioma	0.00269	0.00474	CcSEcCtD
Valaciclovir—Abdominal pain—Carmustine—malignant glioma	0.00269	0.00474	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Temozolomide—malignant glioma	0.00269	0.00473	CcSEcCtD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00269	0.0159	CbGpPWpGaD
Valaciclovir—Urticaria—Temozolomide—malignant glioma	0.00261	0.0046	CcSEcCtD
Valaciclovir—Abdominal pain—Temozolomide—malignant glioma	0.0026	0.00458	CcSEcCtD
Valaciclovir—Body temperature increased—Temozolomide—malignant glioma	0.0026	0.00458	CcSEcCtD
Valaciclovir—Hypersensitivity—Carmustine—malignant glioma	0.0025	0.00441	CcSEcCtD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—malignant glioma	0.00249	0.0148	CbGpPWpGaD
Valaciclovir—Asthenia—Carmustine—malignant glioma	0.00244	0.0043	CcSEcCtD
Valaciclovir—Hypersensitivity—Temozolomide—malignant glioma	0.00242	0.00426	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—SLC5A5—malignant glioma	0.00237	0.014	CbGpPWpGaD
Valaciclovir—Asthenia—Temozolomide—malignant glioma	0.00236	0.00415	CcSEcCtD
Valaciclovir—Diarrhoea—Carmustine—malignant glioma	0.00233	0.0041	CcSEcCtD
Valaciclovir—Pruritus—Temozolomide—malignant glioma	0.00232	0.0041	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00227	0.0134	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC6A3—malignant glioma	0.00226	0.0134	CbGpPWpGaD
Valaciclovir—Dizziness—Carmustine—malignant glioma	0.00225	0.00396	CcSEcCtD
Valaciclovir—Diarrhoea—Temozolomide—malignant glioma	0.00225	0.00396	CcSEcCtD
Valaciclovir—Dizziness—Temozolomide—malignant glioma	0.00217	0.00383	CcSEcCtD
Valaciclovir—Vomiting—Carmustine—malignant glioma	0.00216	0.00381	CcSEcCtD
Valaciclovir—Rash—Carmustine—malignant glioma	0.00214	0.00378	CcSEcCtD
Valaciclovir—Dermatitis—Carmustine—malignant glioma	0.00214	0.00377	CcSEcCtD
Valaciclovir—Headache—Carmustine—malignant glioma	0.00213	0.00375	CcSEcCtD
Valaciclovir—Vomiting—Temozolomide—malignant glioma	0.00209	0.00368	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00208	0.0123	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00208	0.0123	CbGpPWpGaD
Valaciclovir—Rash—Temozolomide—malignant glioma	0.00207	0.00365	CcSEcCtD
Valaciclovir—Dermatitis—Temozolomide—malignant glioma	0.00207	0.00365	CcSEcCtD
Valaciclovir—Headache—Temozolomide—malignant glioma	0.00206	0.00363	CcSEcCtD
Valaciclovir—Nausea—Carmustine—malignant glioma	0.00202	0.00356	CcSEcCtD
Valaciclovir—Nausea—Temozolomide—malignant glioma	0.00195	0.00344	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—malignant glioma	0.00191	0.0113	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—FTH1—malignant glioma	0.0019	0.0112	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—RTEL1—malignant glioma	0.00185	0.011	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00182	0.0107	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00177	0.0105	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.00172	0.0102	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00166	0.00983	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—APOD—malignant glioma	0.00162	0.00956	CbGpPWpGaD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00158	0.00936	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—PDGFB—malignant glioma	0.00151	0.00894	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0015	0.0089	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00149	0.00885	CbGpPWpGaD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00147	0.00869	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00142	0.00842	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0014	0.00826	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00132	0.00783	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00128	0.00758	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00124	0.00735	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00122	0.00723	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—COX8A—malignant glioma	0.00106	0.0063	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00104	0.00613	CbGpPWpGaD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00102	0.00604	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000982	0.00582	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000951	0.00563	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000912	0.0054	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ASMT—malignant glioma	0.000904	0.00535	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000904	0.00535	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000898	0.00532	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000884	0.00523	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BCAN—malignant glioma	0.00085	0.00503	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000834	0.00494	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00083	0.00491	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000827	0.00489	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000811	0.0048	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00079	0.00468	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000785	0.00465	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000764	0.00452	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000759	0.0045	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000742	0.00439	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000729	0.00431	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000723	0.00428	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000709	0.0042	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000707	0.00418	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—IDH2—malignant glioma	0.000685	0.00406	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000677	0.00401	CbGpPWpGaD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000673	0.00398	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000656	0.00388	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000648	0.00384	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000646	0.00383	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2B6—malignant glioma	0.000644	0.00381	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000631	0.00373	CbGpPWpGaD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000624	0.0037	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000619	0.00366	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—IDH1—malignant glioma	0.000589	0.00349	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000583	0.00345	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SPHK1—malignant glioma	0.00057	0.00338	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP2C18—malignant glioma	0.000559	0.00331	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000555	0.00329	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000541	0.0032	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000527	0.00312	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.000526	0.00312	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000487	0.00288	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00048	0.00284	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000463	0.00274	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000463	0.00274	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—malignant glioma	0.000452	0.00268	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS1—malignant glioma	0.000423	0.00251	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000422	0.0025	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BCHE—malignant glioma	0.000394	0.00233	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000391	0.00232	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC5A5—malignant glioma	0.000389	0.0023	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000368	0.00218	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000364	0.00216	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000363	0.00215	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000359	0.00213	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000358	0.00212	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000342	0.00202	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000333	0.00197	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000328	0.00194	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000323	0.00191	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000318	0.00188	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000317	0.00188	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—malignant glioma	0.000313	0.00185	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CAT—malignant glioma	0.000305	0.0018	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000296	0.00175	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOR1—malignant glioma	0.000288	0.0017	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000282	0.00167	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000269	0.00159	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000247	0.00146	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000235	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CAV1—malignant glioma	0.000235	0.00139	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000224	0.00133	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CG—malignant glioma	0.000214	0.00127	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—malignant glioma	0.000206	0.00122	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CD—malignant glioma	0.000188	0.00111	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CB—malignant glioma	0.000164	0.000969	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—malignant glioma	0.000162	0.000961	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000155	0.000917	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000144	0.000851	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—malignant glioma	0.000142	0.000838	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000128	0.000757	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000107	0.000632	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—malignant glioma	9.98e-05	0.000591	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—AKT1—malignant glioma	8.16e-05	0.000483	CbGpPWpGaD
